Tag: Zhang Jing
Firms advise on Insilico Medicine’s HKD2.28bn HKEX IPO
AI drug discovery firm Insilico Medicine listed on the HKEX main board on 30 December 2025
Firms assist on Alibaba’s USD3.2bn convertible senior notes
Linklaters, Fangda, and Jingtian advised on Alibaba’s USD3.2b zero-coupon convertible senior notes offering






















